The Predictors of Remission in Major Depressive Disorder

被引:3
|
作者
Akkaya, Cengiz [1 ]
Eker, Salih Saygin [1 ]
Sarandol, Asli [1 ]
Cangur, Sengul [2 ]
Kirli, Selcuk [1 ]
机构
[1] Uludag Univ, Tip Fak, Psikiyatri Anabilim Dali, Bursa, Turkey
[2] Uludag Univ, Tip Fak, Biyoistat Anabilim Dali, Bursa, Turkey
来源
关键词
Major depressive disorder; remission; antidepressant; POST-HOC ANALYSIS; CLINICAL PREDICTORS; TREATMENT RESPONSE; FAMILY-HISTORY; RATING-SCALE; DOUBLE-BLIND; EFFICACY; REBOXETINE; SERTRALINE; TOLERABILITY;
D O I
10.4274/npa.y6279
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: We aimed to determine the predictors of remission in major depressive disorder (MDD) with antidepressant treatment (AT). Methods: The subjects were recruited from the databases of the previous four studies. 178 patients were separated in to two groups at the final visit regarding remission. The patients were analyzed in terms of sociodemographic and clinical features regardless of their AT. Results: The difference in sociodemographic and clinical features was insignificant between the groups. Remitted patients had lower scores on the Hamilton Depression Rating Scale (HORS), Montgomery-Asberg Depression Scale, Hamilton Anxiety Rating Scale, and the Clinical Global Impression Scale compared to baseline whereas Social Adaptation Self-evaluation Scale (SASS) scores were higher. To evaluate the impact of basal scores of HORS and SASS on non remission rates, logistic regression analysis was performed. The analysis result was significant (p<0.001). Valid classification rate was 66% for this model. For this model, the scores of HORS and SASS at visit 1 are significant risk factors for non-remission (p<0.001). As the value of HORS increases, the risk of non-remission increases 1.095 fold (Odds ratio 95%, confidence interval: 1.045-1.147), whereas as the value of SASS decreases the risk of non-remission increases 1,076 fold (Odds ratio 95%, confidence interval: 1.042-1.114). For each patient, non-remission possibility can be predicted by "p(non remission)=1/[(1+exp (-0,093xV1HDRS+0,075xV1SASS)]" equivalent via this model. Conclusion: The findings of the present study suggest that severe level of depression, anxiety and social maladaptation at baseline are more likely to predict remission.
引用
收藏
页码:122 / 129
页数:8
相关论文
共 50 条
  • [1] Predictors of remission from generalized anxiety disorder and major depressive disorder
    Kelly, Kristen M.
    Mezuk, Briana
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2017, 208 : 467 - 474
  • [2] Predictors of remission from major depressive disorder in secondary care
    Salvo, Lilian
    Saldivia, Sandra
    Parra, Carlos
    Cifuentes, Manuel
    Bustos, Claudio
    Acevedo, Paola
    Diaz, Marcela
    Ormazabal, Mitza
    Guerra, Ivonne
    Navarrete, Nicol
    Bravo, Veronica
    Castro, Andrea
    [J]. REVISTA MEDICA DE CHILE, 2017, 145 (12) : 1514 - 1524
  • [3] Predictors of fluoxetine remission for hospitalized patients with major depressive disorder
    Lin, Ching-Hua
    Lane, Hsien-Yuan
    Chen, Cheng-Chung
    Juo, Suh-Hang Hank
    Yen, Cheng-Fang
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2011, 65 (05) : 510 - 517
  • [4] Adjunctive aripiprazole in major depressive disorder (MDD): efficacy and predictors of remission
    Nelson, J. C.
    Thase, M. E.
    Baker, R. A.
    Rollin, L. M.
    McQuade, R. D.
    Marcus, R. N.
    Berman, R. M.
    Wisniewski, S. R.
    Gismondi, R.
    Loze, J. Y.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S386 - S386
  • [5] Psychosocial and Clinical Predictors of Symptom Persistence vs Remission in Major Depressive Disorder
    Enns, Murray W.
    Cox, Brian J.
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (12): : 769 - 777
  • [6] Imaging predictors of remission to anti-depressant medications in major depressive disorder
    Chi, Kee F.
    Korgaonkar, Mayuresh
    Grieve, Stuart M.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2015, 186 : 134 - 144
  • [7] quality of remission in the major depressive disorder
    Chebli, H.
    Berrada, H.
    Chtibi, M.
    Belbachir, S.
    Ouanass, A.
    [J]. EUROPEAN PSYCHIATRY, 2023, 66 : S832 - S832
  • [8] Remission and functioning in major depressive disorder
    Romera, Irene
    Perez, Victor
    Gilaberte, Inmaculada
    [J]. ACTAS ESPANOLAS DE PSIQUIATRIA, 2013, 41 (05): : 263 - 268
  • [9] Neural correlates of remission in major depressive disorder
    Scharinger, C.
    Hartinger, B.
    Diers, K.
    Rabl, U.
    Bartova, T.
    Sitte, H.
    Windischberger, C.
    Moser, E.
    Brocke, B.
    Kasper, S.
    Pezawas, L.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 196 - 196
  • [10] Major depressive disorder: Remission of associated symptoms
    Trivedi, Madhukar H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 : 27 - 32